Home

Cognition

Read time: 3 min

Satellite symposium

Can early intervention prevent progressive loss of brain and cognitive capacity?

Given imaging and cognitive science evidence that bipolar disorder is neuroprogressive, early...

Read time: 2 min

Congress highlights

Key interventions for a better life living with schizophrenia

Patients with schizophrenia can live better lives within the community when managed by continuous...

Read time: 2 min

Congress highlights

Social isolation- a portal to pathology

Social isolation, of the kind made worse by COVID-19, affects many systems relevant to mental...

Read time: 3 min

Cognizing about cognition

Metacognition - or as Plato put it ‘cognizing about cognition’ - is the buzzword in...

Parkinson's Disease

Is mild cognitive impairment in Parkinson’s disease a useful diagnosis?

The question is one of neurology’s many enduring and intriguing debates. At the AAT-AD/PD...

Is mild cognitive impairment in Parkinson’s disease a useful diagnosis?

Read time: 2 min

Seasonal problems will be magnified by Covid-19

For people with mental illness or disabling neurological conditions, restrictions imposed to...

Read time: 3 min

Congress highlights

From diagnostic categories to underlying dysfunction

Can one-size-fits-all diagnoses be replaced by a symptom-based approach which acknowledges the...

Alzheimer's Disease, Parkinson's Disease

Read time: 3 min

Winter poses climatic and cultural challenges

Seasonal fluctuations in the symptoms of Alzheimer’s and Parkinson’s Diseases may...

Read time: 2 min

Congress highlights

PRISM casts revealing light on symptoms that cross diagnostic categories

The PRISM project is multidisciplinary, quantitative, biology-based and – above all –...

Targeting what matters most for patients with depression: Strategies for promoting full functional recovery

Read the full article here.

Targeting what matters most for patients with depression: Strategies for promoting full functional recovery

Read time: 3 min

Satellite symposium

Balancing efficacy and tolerability to personalize treatment choices in schizophrenia

The Precision Medicine Initiative was launched in 2015 in the United States. This approach to...

Read time: 3 min

Congress highlights

How do we help patients with severe mental disorders live longer and healthier?

Many patients with severe mental disorders have behavioral risk factors for chronic disease,...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country